CLASS II ONGOING Drug recall · Reported 22 Oct 2025 · FDA Enforcement Report

Fasenra (benralizumab) Injection, 30 mg/mL recalled

Astrazeneca Pharmaceuticals is recalling Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, distributed nationwide in the US. The recall was initiated on 8 Oct 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot YJ0152, Expiry: 01/31/2028.
NDC0310-1730, 0310-1830, 0310-1745
Quantity recalled916 pre-filled syringes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0028-2026
FDA event ID
97760
Recalling firm
Astrazeneca Pharmaceuticals, Gaithersburg, MD
Brand
Fasenra
Manufacturer
AstraZeneca Pharmaceuticals LP
Classification
Class II
Status
Ongoing
Recall initiated
8 Oct 2025
FDA classified
16 Oct 2025
Reported
22 Oct 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Sterility

Timeline

8 Oct 2025Recall initiated by company
16 Oct 2025Classified by FDA+8 days
22 Oct 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility:

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30

Where it was distributed

Nationwide in the U.S

Nationwide

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility:

Which lots are affected?

Lot YJ0152, Expiry: 01/31/2028.

Where was it sold?

Nationwide in the U.S

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Astrazeneca Pharmaceuticals

All 6